LEAD MODEL 304
Report
- Report Number
- 1644487-2012-03305
- Event Type
- Injury
- Date Received
- December 12, 2012
- Date of Event
- November 7, 2012
- Report Date
- November 19, 2012
- Manufacturer
- CYBERONICS, INC.
- Product Code
- LYJ
- PMA / PMN Number
- P970003
- Removal / Correction Number
- NA
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- AL, US
- Reporter Occupation
- OTHER
Narratives
ADDITIONAL INFORMATION WAS RECEIVED THAT THE PATIENT IS SEIZURE FREE AND HIS VOICE IS BACK TO. AS NOTED AT HIS FOLLOW UP OFFICE VISIT THE WEEK OF (B)(6) 2013.
A VNS PATIENT CALLED TO REPORT THAT SINCE THEIR IMPLANT (B)(6) 2012, THEY WERE HAVING ISSUES. IT WAS REPORTED THAT SINCE HE HAD HIS VNS PLACED, HE HAS HAD SHORTNESS OF BREATH AND VOICE ALTERATION THAT WON'T GO AWAY. THE PATIENT ALSO REPORTED THAT HE HAD ONE OF THE WORST SEIZURES LAST NIGHT THAT HE HAS EVER HAD. THE PATIENT'S VNS WAS NOT PROGRAMMED ON. THE PATIENT REPORTED THAT THEIR NEUROLOGY OFFICE WOULD NOT PROGRAM HIS VNS ON TILL HIS SHORTNESS OF BREATH AND VOICE ALTERATION RESOLVE. THE ESTIMATED TIME OF SURGERY WAS 45 MINUTES. THERE WERE NO COMPLICATIONS REPORTED DURING THE PROCEDURE. FINAL INTERROGATION SHOWED DEVICE WAS AT 0.0 OUTPUT CURRENT, AND 0.0 MAGNET CURRENT. THE PATIENT WAS SEEN BY AN ENT PHYSICIAN AND IT WAS NOTED THAT HIS LEFT VOCAL CORD WAS "WEAK" DUE TO VOCAL CORD PARALYSIS. THE PATIENT REPORTED THAT THE ENT AND IMPLANTING SURGEON SAID HIS DEVICE COULD BE TURNED. THE PATIENT ALSO NO LONGER REPORTS SHORTNESS OF BREATH, BUT STILL HAS HOARSENESS. THE PATIENT IS SCHEDULED TO HAVE A PROCEDURE WITH THE ENT TO ADJUST HIS VOCAL CORDS CLOSER TOGETHER USING A SCOPE. FURTHER FOLLOWUP WILL BE PERFORMED TO ATTAIN MORE DETAILS ABOUT THE REPORTED EVENTS.
GOOD FAITH ATTEMPTS WERE MADE AND NO FURTHER INFORMATION WAS ATTAINED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | LEAD MODEL 304 | LEAD MODEL 304 | LYJ | CYBERONICS, INC. | 304-20 | 3359 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 39 YR | Required Intervention |